Andrew Douglas Baxter,Jonathan Morris,Andrew David Morley
申请号：
US16651182
公开号：
US20200270249A1
申请日:
2018.09.26
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Anti-angiogenic treatments, for example treatment of ocular neovascularization or cancer, treatments of hyperpermeability disorders, treatments of neuropathic and neurodegenerative disorders, pain treatments, methods of treating or preventing fibrosis and compounds for use in such methods are described.
